Publication | Closed Access

Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation

InflammationPulmonary Arterial HypertensionInflammatory Lung DiseaseCardiovascular DiseaseLung InflammationMedicineVascular PharmacologyPhysiologyImmunologyEndothelial DysfunctionPulmonary PharmacologyPulmonary FibrosisVascular BiologyPublic HealthSphk1-mediated Nf-κb ActivationPharmacologyPulmonary Vascular DiseaseOxidative Stress